Cargando…
Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
Coronavirus disease 2019 (COVID-19) is a major threat worldwide due to its fast spreading. As yet, there are no established drugs available. Speeding up drug discovery is urgently required. We applied a workflow of combined in silico methods (virtual drug screening, molecular docking and supervised...
Autores principales: | Kadioglu, Onat, Saeed, Mohamed, Greten, Henry Johannes, Efferth, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008812/ https://www.ncbi.nlm.nih.gov/pubmed/33845270 http://dx.doi.org/10.1016/j.compbiomed.2021.104359 |
Ejemplares similares
-
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
por: Saeed, Mohamed E. M., et al.
Publicado: (2020) -
Identification of Novel Rare ABCC1 Transporter Mutations in Tumor Biopsies of Cancer Patients
por: Kadioglu, Onat, et al.
Publicado: (2020) -
Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
por: Kadioglu, Onat, et al.
Publicado: (2018) -
Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin—Two Main Metabolites of Curcuma longa—in Cancer Cells
por: Ooko, Edna, et al.
Publicado: (2017) -
Pharmacogenomics of Scopoletin in Tumor Cells
por: Seo, Ean-Jeong, et al.
Publicado: (2016)